Publications

Search publications

22.04.26

An open-source PBBM integrating the particle drifting effect to predict human oral absorption of nanoparticle formulations

PBPK & PBBM

Pharmacometrics

Methodology

PBPK Conference 2026, Poster 16

Kister B, Eriksson J, Sjögren E

04.03.26

Model-based bioequivalence methods open new doors for generics

MIDD

Pharmacometrics

Methodology

ASCPT (Mar 2026) PII-047.

Bjugård Nyberg H, Hooker A, Bergstrand M, Chenel M, Jonsson EN

21.02.26

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025

PBPK & PBBM

Trial design and analysis

Regulatory interactions

Specific populations

Methodology

CPT Pharmacometrics Syst Pharmacol. 2026 Mar;15(3):e70217. Online ahead of print

Cordes H, Annaert P, Balazki P, Benamara S, Bonan RH, Butler A, Chenel M, Cui Y, Dallmann A, de Witte WEA, Demeester C, Feick D, Gattacceca F, Geci R, Gerebtzoff G, Gruber A, Guimarães M, Hamadeh A, Hanke N, Ibarra M, Ince I, Kanacher T, Kuepfer L, Mil F, Montaseri G, Nauwelaerts N, Proenca S, Schaller S, Schlender JF, Schneider ARP, Sjögren E, Solodenko J, Staab A, Vrenken P, Troisi C, Teutonico D.

28.01.26

Conditional versus unconditional covariate effects in pharmacometric models: implications for interpretation, communication, and reporting

Regulatory interactions

Pharmacometrics

Methodology

CPT Pharmacometrics Syst Pharmacol. 2026 Feb;15(2):e70203.

Jonsson EN, Jönsson S, Hansson E, Nyberg J.

09.01.26

Risks encountered when not adjusting for diurnal variation and food effect in QTcF analysis based on Phase I data

MIDD

Pharmacometrics

Methodology

J Pharmacokinet Pharmacodyn. 2026 Feb;53(1):6.

Bardol M, Sarr C, Henrich A, Mezzalana E, Langenhorst J

22.12.25

Prediction of Monoclonal Antibodies Pharmacokinetics in Human: Identification of a Reference Neonatal Fc Receptor (FcRn) Binding Affinity Using Physiologically Based Pharmacokinetic (PBPK) Modeling

PBPK & PBBM

Program strategies and efficiencies

ACS Pharmacol. Transl. Sci. 2025 Dec 22. Online ahead of print.

Benamara S, Sjögren E, Gattacceca F, Chenel M, Deslandes A, Nguyen L, Teutonico D

09.12.25

Population Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of FVC‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib

MIDD

Regulatory interactions

Specific populations

Pharmacometrics

Respiratory

Program strategies and efficiencies

Methodology

CPT Pharmacometrics Syst Pharmacol. 2025 Dec 9. Online ahead of print.

Hartman S, Chan Kwong A, Ribbing J, Gahlemann M, Korell J

25.11.25

Quantitative Relationship Between Tominersen Concentrations in Cerebrospinal Fluid and Biomarker Changes in Huntington's Disease Patients

Trial design and analysis

Pharmacometrics

CNS

Genetic

Br J Clin Pharmacol. 2025 Nov 25. Online ahead of print.

Yamamoto Y, Silber Baumann HE, Björnsson MA, Grimsey P, Hawellek DJ, Anderson K, Leavitt BR, Landwehrmeyer BG, Tabrizi S, McColgan P, Wild EJ, Sanwald Ducray P.

Search publications

Publications

Related content

Science & Services

Latest news

People & Culture